Branched-chain ketoacids in encephalopathy
β Scribed by H. Franklin Herlong; Willis C. Maddrey; Mackenzie Walser; Ljusk Siw Eriksson; Harold O. Conn
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 237 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
After careful analysis of the literature, Eriksson and Conn (1) concluded that branched-chain amino acid (BCAA) therapy does not appear to significantly affect the prognosis of patients with acute hepatic encephalopathy (HE). In a metanalysis of almost the same studies, Naylor et al. (2) reached the
## Abstract In order to determine whether branchedβchain ketoacids can reduce the excessive rate of muscle protein degradation that characterizes Duchenne muscular dystrophy, nine boys affected with the disease were studied in a metabolic ward while receiving meatβfree diets. After a threeβday equi
Branched-chain ketoacids were isolated from plasma or serum samples by acidification, passage through a cationic exchange resin, ether extraction, and extraction of the ether layer with phosphate buffer. The recovery of 2-[ l-14C]ketoisocaproate taken through these procedures averaged 95 + 3%. Branc
A new method using hydrophobic interaction chromatography on phenyl-Sepharose was developed to purify branched chain Lu-ketoacid dehydrogenase complex from commercially available frozen rat liver. Yields of greater than 50% were routinely achieved. The purified enzyme, composed of Elc~, El& and E2 s
The authors undertook a meta analysis of nine randomized clinical trials (RCTs) in which modified amino acid solutions that contained supplemental amounts of branched-chain amino acids (BCAA) were compared with other forms of therapy of hepatic encephalopathy (HE). When five RCTs were pooled, analys